Properties
Description
MG-262 interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma.
Molecular Formula
C25H42BN3O6
Identity
Confirmed by NMR/HPLC/MS.
Applications
MG-262 is applied in research targeting the inhibition of proteasome activity, notably in cancer studies.